Showing results (371-380 of 3,787) with videos related to

Sort By:
Pageof 379
Oncoimmunology|June 10, 2025
Combining local cytokine delivery and systemic immunization with recombinant artLCMV boosts antitumor efficacy in several preclinical tumor modelsKimberly Pojar, Diana Reckendorfer, Judith Strauss, et al.
Oncoimmunology|July 20, 2025
CD200 immune checkpoint expression is associated with inferior outcome in multiple myeloma patients treated with anti-CD38 monoclonal antibodiesDjamila Chemlal, Camille Pochard, Valentin Jacquier, et al.
Oncoimmunology|October 7, 2025
Tumor-infiltrating lymphocytes-derived CD8+ clonotypes infiltrate the tumor tissue and mediate tumor regression in glioblastomaLucas C M Arruda, Julia Karbach, Dragan Kiselicki, et al.
Oncoimmunology|July 10, 2025
Disruption of cholesterol homeostasis by antidepressants induces immunogenic cell deathKarla Alvarez-Valadez, Jonathan G Pol, Guido Kroemer, et al.
Oncoimmunology|July 9, 2025
An SNP-dependent cancer-testis antigenic epitope serves as a promising immunotherapeutic target for cancerKenji Murata, Tomoyuki Minowa, Tomohide Tsukahara, et al.
Oncoimmunology|July 15, 2025
An immunological mechanism of resistance to CDK4/6 inhibitors in HR+ breast cancerClaudia Galassi, Giulia Petroni, Simon R V Knott, et al.
Oncoimmunology|July 4, 2025
Benzodiazepines interfere with the efficacy of pembrolizumab-based cancer immunotherapy. Results of a nationwide cohort study including over 50,000 participants with advanced lung cancerLéa Montégut, Adrien Rousseau, Cinzia Ungolo, et al.
Oncoimmunology|January 7, 2026
The LXRβ/NF-κB axis reprograms CAR-T cells to resist exhaustion in the tumor microenvironmentMinji Lim, Sang-Eun Jung, Choong-Hyun Koh, et al.
Oncoimmunology|December 16, 2025
Mild microwave hyperthermia promotes mitotic catastrophe, induces time-delayed cGAS-STING activation and restores sensitivity to anti-PDL1 therapy in Pan02 pancreatic cancer modelNa Li, Jiamin He, Mengjiao Chen, et al.
Oncoimmunology|December 12, 2025
Virus nanoparticle intratumoral vaccines for HER2+ malignanciesMiguel A Moreno-Gonzalez, Jessica Fernanda Affonso de Oliveira, Manuel L Penichet, et al.
Pageof 379